Sign in

INNPF on OTC

INNOCAN PHARMA Corp

INNOCAN PHARMA Corp is a pharmaceutical preparations company based in Calgary, listed on OTC (INNPF).1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerINNPF on OTC1
  • IndustryPharmaceutical Preparations1
  • HeadquartersZ41
  • Incorporated inCanada (Federal Level)2
  • Business address1015, 926 - 5 Avenue Sw, Calgary, T2P 0N72
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorIris Bincovich named Oct 26, 20213
  • Executive OfficerNelson A. Halpen named Oct 26, 20213
  • Executive Officer, DirectorRon Mayron named Oct 26, 20213
  • Executive Officer, DirectorYoram Drucker named Oct 26, 20213
  • DirectorEyal Flom named Oct 26, 20213
  • DirectorJoshua A. Lintern named Oct 26, 20213
  • DirectorPeter A. Bloch named Oct 26, 20213
  • DirectorRalph Bossino named Oct 26, 20213

Filings

48 filings to the SEC since October 2021: 1 private raises, 47 other. The latest 20:

  1. Apr 3, 2026FWP EDGAR
  2. Apr 3, 2026F-1/A EDGAR
  3. Mar 16, 2026FWP EDGAR
  4. Mar 16, 2026F-1 EDGAR
  5. Feb 23, 2026RW EDGAR
  6. Jan 30, 2026EFFECT EDGAR
  7. Jan 27, 2026CORRESP EDGAR
  8. Jan 27, 2026CORRESP EDGAR
  9. Jan 7, 2026F-1/A EDGAR
  10. Jan 6, 2026FWP EDGAR
  11. Jan 6, 2026F-1/A EDGAR
  12. Dec 22, 20258-A12B/A EDGAR
  13. Dec 19, 20258-A12B/A EDGAR
  14. Dec 16, 20258-A12B/A EDGAR
  15. Dec 10, 2025FWP EDGAR
  16. Dec 10, 2025F-1/A EDGAR
  17. Nov 10, 2025DEL AM EDGAR
  18. Oct 22, 2025F-1/A EDGAR
  19. Oct 1, 2025FWP EDGAR
  20. Sep 30, 2025F-1/A EDGAR

The 48 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$6.6M 2021–2021
Money received by yearMoney received by year, 2021–2021: $6.6M in all. Private raises (Form D) $6.6M.$0$2M$4M$6M$8M2021 · Private raises (Form D): $6.6M2021
Figures by year
YearPrivate raises (Form D)Total
2021$6.6M$6.6M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Oct 13, 2021Raised $6.6 million in a private offering of equity3 Form D: 8 investors so far Form D

SEC filer profile

How INNOCAN PHARMA Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARINNOCAN PHARMA Corp1
  • CIK0001889791
  • Incorporated inCanada (Federal Level)1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1015, 926 - 5 Avenue Sw, Calgary, T2P 0N7, Canada (Federal Level)1
  • Phone403-777-15191
  • On EDGAR sinceOct 26, 20211
  • Filings48 in all: F-1/A (8), CORRESP (7), FWP (7), UPLOAD (6), DRS/A (5), DRSLTR (4), 8-A12B/A (3), F-1 (2)1
    All 14 form types

    8-A12B (1), D (1), DEL AM (1), DRS (1), EFFECT (1), RW (1)

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3